Death Attitude (Implicit/Explicit)NCT07525492
Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial
A study testing Death Conversation and Online ACP Education in people with Death Attitude (Implicit/Explicit) and Death Anxiety, run by National University of Singapore at 1 site in Singapore.
Trial summary
The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life… Read more about this study
- Who is it for?
- Ages 40 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Death Attitude (Implicit/Explicit), Death Anxiety, End of Life Care
- What is being tested?
- Death Conversation and Online ACP Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 148 participants
- Where
- 1 siteSingapore
- Study dates
- 1 Apr 2026to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Between the ages of 40 to 60 years
- Able to comprehend the English language
- Have not completed any form of advance directives
- Able and willing to participate in the Die-logue programme and surveys
Who cannot join
- Individuals diagnosed with any life limiting diseases
- Individuals with self-reported history of mental health disorders or neurological disorders
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Singapore1 site
National University of Singapore
Singapore
Darryl Ang, PhD, +65 65167792, darrylang@nus.edu.sg
About this study
Official title: Effects of a Die-logue Program in Enhancing Community Dwelling Adults's Death Attitudes, Coping With Death and Readiness for Advance Care Planning: A Two-phase Study
The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life limiting diseases.
This study aims to address the following research questions:
Read more
- Does the Die-logue program improve community-dwelling middle-aged adults' attitudes towards death, ability to cope with death, readiness and uptake for Advanced Care Planning (ACP).
- What are community-dwelling middle-aged adults' perceptions of advance care planning, death and dying, and their experiences of participation in the Die-logue program.
Researchers will compare participants who receive the Die-logue program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve attitudes toward death, coping with death, and readiness for ACP.
Participants will:
- Complete online questionnaires measuring attitudes toward death, coping with death, and readiness for advance care planning.
- Participate in a facilitator-led group discussion session about perceptions of death, coping with death, and readiness for ACP (intervention group only).
- Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
- Complete follow-up surveys, including a 6-month follow-up assessing whether they have undertaken advance care planning.
- Conditions
- Death Attitude (Implicit/Explicit), Death Anxiety, End of Life Care, Advanced Care Planning (ACP)
- Being tested
- Death Conversation, Online ACP Education
- Keywords
- Death Conversation, Death Anxiety, Advance Care Planning, Death Attitude
- Medical subject headings
- Necrophobia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Death ConversationBehavioural
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Perceptions of death and dying. 2) Coping with death. 3) Readiness for Advance Care Planning (ACP)
Online ACP EducationBehavioural
An online asynchronous learning session with short videos on ACP with discussion forums.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Participants in this arm will receive the two-session Die-logue Program.
Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:
1. Perceptions of death and dying.
2. Coping with death.
3. Readiness for Advance Care Planning (ACP).
Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums. Receives: Behavioral: Death Conversation; Behavioral: Online ACP Education |
| Control Group | Active comparator | Participants in this arm will only receive the online ACP education component, identical to Session 2 of the Die-logue programme. No facilitator-led group discussions are provided. Receives: Behavioral: Online ACP Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Measured: Before intervention
Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Measured: Immediately after intervention
Secondary outcomes (8)
Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Measured: Before intervention
Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Measured: Immediately after intervention
Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Measured: 6 months after intervention
Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Measured: 6 months after intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Measured: Before intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Measured: Immediately after intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Measured: 6 months after intervention
Uptake of Advance Care Planning
Self-reported completion of Advance Care Planning Activities
Measured: 6 months after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study start1 Apr 2026 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Death Attitude (Implicit/Explicit)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 148 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National University of Singapore
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ang Wei How Darryl, National University of Singapore
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07525492
- Sponsor's protocol ID
- NUS-IRB-2025-243
- Other IDs
- NUHSRO/2025/007/RO5+5/Seed-Sep
- Status last verified
- Mar 2026
- First submitted
- 6 Apr 2026
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of a Die-logue Program in Enhancing Community Dwelling Adults's Death Attitudes, Coping With Death and Readiness for Advance Care Planning: A Two-phase Study
- ClinicalTrials.gov ID
- NCT07525492
- Acronym / sponsor ID
- NUS-IRB-2025-243
- Conditions
- Death Attitude (Implicit/Explicit), Death Anxiety, End of Life Care, Advanced Care Planning (ACP)
- Keywords
- Death Conversation, Death Anxiety, Advance Care Planning, Death Attitude
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 148 participants (estimated)
- Lead sponsor
- National University of SingaporeUniversity, hospital or other
- Study start
- 1 Apr 2026 (estimated)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life limiting diseases.
This study aims to address the following research questions:
- Does the Die-logue program improve community-dwelling middle-aged adults' attitudes towards death, ability to cope with death, readiness and uptake for Advanced Care Planning (ACP).
- What are community-dwelling middle-aged adults' perceptions of advance care planning, death and dying, and their experiences of participation in the Die-logue program.
Researchers will compare participants who receive the Die-logue program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve attitudes toward death, coping with death, and readiness for ACP.
Participants will:
- Complete online questionnaires measuring attitudes toward death, coping with death, and readiness for advance care planning.
- Participate in a facilitator-led group discussion session about perceptions of death, coping with death, and readiness for ACP (intervention group only).
- Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
- Complete follow-up surveys, including a 6-month follow-up assessing whether they have undertaken advance care planning.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Behavioral: Death Conversation, Behavioral: Online ACP EducationParticipants in this arm will receive the two-session Die-logue Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering: 1. Perceptions of death and dying. 2. Coping with death. 3. Readiness for Advance Care Planning (ACP). Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums. |
| Control Group | Active comparator | Behavioral: Online ACP EducationParticipants in this arm will only receive the online ACP education component, identical to Session 2 of the Die-logue programme. No facilitator-led group discussions are provided. |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Between the ages of 40 to 60 years
- Able to comprehend the English language
- Have not completed any form of advance directives
- Able and willing to participate in the Die-logue programme and surveys
Key exclusion criteria (2 listed)
- Individuals diagnosed with any life limiting diseases
- Individuals with self-reported history of mental health disorders or neurological disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Death ConversationOn site, facilitator-led group discussion lasting 2 hours, covering: 1) Perceptions of death and dying. 2) Coping with death. 3) Readiness for Advance Care Planning (ACP) | Behavioural | Intervention Group |
| Online ACP EducationAn online asynchronous learning session with short videos on ACP with discussion forums. | Behavioural | Control Group, Intervention Group |
Primary outcome
Death Attitudes
Time frame: Before intervention
Death Attitude Profile Revised Scale (DAP-R)
Death Attitudes
Time frame: Immediately after intervention
Death Attitude Profile Revised Scale (DAP-R)
8 secondary outcomes
Coping with Death
Time frame: Before intervention
Coping with Death
Time frame: Immediately after intervention
Coping with Death
Time frame: 6 months after intervention
Death Attitudes
Time frame: 6 months after intervention
Readiness for Advance Care Planning
Time frame: Before intervention
Readiness for Advance Care Planning
Time frame: Immediately after intervention
Readiness for Advance Care Planning
Time frame: 6 months after intervention
Uptake of Advance Care Planning
Time frame: 6 months after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
Related trials for Death Attitude (Implicit/Explicit)
Not yet recruiting
Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses
Death Anxiety, Death Attitude (Implicit/Explicit)
Not yet recruitingObservational study
Chinese University Students' Death Attitudes and Their Initial Sandplay Characteristics
Death Attitude (Implicit/Explicit), Sandplay Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Death Conversation and Online ACP Education in people with Death Attitude (Implicit/Explicit) and Death Anxiety, run by National University of Singapore at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Darryl Ang, PhD (+65 65167792, darrylang@nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Death Attitudes (time frame: Before intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.